Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2003
06/12/2003US20030108896 Method for detection of melanoma
06/12/2003US20030108895 Analyzing cell differentaition of stem cells; drug screening
06/12/2003US20030108893 Method for establishing neurogically relevant properties of a material
06/12/2003US20030108892 Exciplexes
06/12/2003US20030108890 Such as analysis of guanylate cyclase levels for progression of colon cancer; cell differentiation
06/12/2003US20030108888 Breast cancer antigens
06/12/2003US20030108887 Zinc finger proteins; genomes
06/12/2003US20030108883 Protein tyrosine phosphatase 1B (PTP1B); insulin resistance
06/12/2003US20030108882 Nucleic acid encoding a retinoblastoma binding protein (RBP-7) and polymorphic markers associated with said nucleic acid
06/12/2003US20030108879 Polymer brushes for immobilizing molecules to a surface or substrate having improved stability
06/12/2003US20030108877 Methods for selecting and producing selective pharmaceutical compounds and compositions using an established genetically altered cell-based library responsive to transcription factors; genetic constructs and library therefor.
06/12/2003US20030108876 Method for the application of FTMS to drug testing
06/12/2003US20030108872 Genomics-assisted rapid identification of targets
06/12/2003US20030108871 Genes expressed in treated human C3A liver cell cultures
06/12/2003US20030108870 DNA amplification with a first primer having a random sequence of nucleotides at its 3'end and a generic sequence 5' of the random nucleotides, as well as a second primer with the generic sequence of the first primer
06/12/2003US20030108869 Leucine zipper domains of reporter molecule hydrolyze penicillin or cephalosporin substrates; gene expression
06/12/2003US20030108865 Polymerase chain reactions; DNA electrophoresis
06/12/2003US20030108862 Genetic probes for hepatitis C virus (HCV) polymerase
06/12/2003US20030108858 Methods for the simultaneous detection of HCV antigens and HCV antibodies
06/12/2003US20030108661 Method and arrangement for determining the profile of a coating layer
06/12/2003US20030108570 Method and kit using recombinant proteins in fusion of porcine reproductive and respiratory syndrome virus and for diagnosis
06/12/2003US20030108563 Blood screening for hepatitis C virus; complexing
06/12/2003US20030108554 GIPs, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein
06/12/2003US20030108553 Detection and treatment of cancers of the liver
06/12/2003US20030108550 Anti-procalcitonin antibodies and the preparation and use thereof
06/12/2003US20030108538 LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies
06/12/2003US20030108490 Method and test kit for avoiding long-term failures in root canal treatments
06/12/2003US20030108484 Individualization of therapy with antineoplastic agents
06/12/2003US20030108483 Non-invasive localization of a light-emitting conjugate in a mammal
06/12/2003US20030108447 Accumulation, measurement, analyzing
06/12/2003US20030108291 Grid-waveguide structure for reinforcing an excitation field and use thereof
06/12/2003US20030108231 Nuclear area and recognizing method and nuclear genealogy creating method
06/12/2003US20030108230 Cell lineage extracting method
06/12/2003US20030107735 Calcium carbonate imaging technique
06/12/2003US20030107729 Method and device for detecting impurities in a longitudinally moving thread-like product
06/12/2003US20030107723 Method and apparatus for measuring blood sugar
06/12/2003US20030107467 Sensor package for harsh environments
06/12/2003US20030107386 Apparatus for and method of making electrical measurements of objects
06/12/2003US20030107012 System, method, and apparatus for non-intrusively determining concentration of a solute in a solution
06/12/2003US20030106998 Method for producing boron nitride coatings and fibers and compositions thereof
06/12/2003US20030106995 Method for measuring absorbed and interstitial fluids
06/12/2003US20030106993 Apparatus and methods for downhole determination of characteristics of formation fluids
06/12/2003US20030106853 Applying electrical signal, measuring impedance of fluid flow
06/12/2003US20030106811 Detecting a gas; multilayer surface containing ionomer membrane
06/12/2003US20030106809 Passive sample detection to initiate timing of an assay
06/12/2003US20030106164 Measuring soil in a wash liquor or other soil-containing liquid medium
06/12/2003DE20305443U1 Device for automatic determination of tablet decomposition times comprises a measuring basket with glass tubes, having a top plate capable of identifying the tube position and the device number
06/12/2003DE20304525U1 Clamping unit for a testing machine for samples of filaments or materials containing filaments varies the clamping force between the clamping elements dependent on the load on the sample
06/12/2003DE10153084C1 Probenahmegerät für Stäube auf Oberflächen Sampling device for dust on surfaces
06/12/2003CA2811997A1 Antibodies against monocyte chemotactic proteins
06/12/2003CA2470508A1 Library screening
06/12/2003CA2469568A1 A method for identifying markers
06/12/2003CA2469477A1 Phenotypic screen of chimeric proteins
06/12/2003CA2469403A1 Protein arrays for allelic variants and uses thereof
06/12/2003CA2469388A1 Computer system and method for calculating adme properties
06/12/2003CA2469356A1 Nuclear protein "shoca" - a component of the wnt signalling pathway
06/12/2003CA2469196A1 Discovery of therapeutic products
06/12/2003CA2469170A1 Method for producing chemical libraries enhanced with biologically active molecules
06/12/2003CA2469151A1 Immunocytokines with modulated selectivity
06/12/2003CA2469104A1 Minor histocompatibility antigen ha-1: target antigen for immunotherapy of tumors
06/12/2003CA2469066A1 Labelled nucleotides
06/12/2003CA2468991A1 Methods and reagents for diagnosis and treatment of diabetes
06/12/2003CA2468907A1 Effectors of innate immunity
06/12/2003CA2468851A1 Gips, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein
06/12/2003CA2468743A1 Direct write nanolithographic deposition of nucleic acids from nanoscopic tips
06/12/2003CA2468734A1 Method and apparatus for detecting the presence of ammonium nitrate and a sugar or a hydrocarbon
06/12/2003CA2468701A1 T-bet compositions and methods of use thereof
06/12/2003CA2468674A1 Microfluidic device and surface decoration process for solid phase affinity binding assays
06/12/2003CA2468601A1 Methods and apparatus for complex genetics classification based on correspondence analysis and linear/quadratic analysis
06/12/2003CA2468457A1 Enzyme activity profiles
06/12/2003CA2468407A1 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
06/12/2003CA2468259A1 Antibody to latent membrane proteins and uses thereof
06/12/2003CA2468144A1 Information processing system using information on base sequence
06/12/2003CA2467587A1 Microfluidic device and methods of using same
06/12/2003CA2467333A1 Methods for monitoring amyotrophic lateral sclerosis
06/12/2003CA2467077A1 Method for determining residual fuel and insolubles contamination in used marine engine lubricants using uv-visible spectroscopy and chemometrics
06/12/2003CA2467073A1 Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases
06/12/2003CA2444434A1 Composition for blood serum or plasma separation and vessel for blood examination containing the same
06/11/2003EP1318472A2 Method for the analysis of molecular expression data and biological networks
06/11/2003EP1318407A1 Use of aldose-1-epimerase (mutarotase) for the diagnosis and therapy of infections and sepsis
06/11/2003EP1318406A1 Use of Glycine-N-Acyl-Transferase (GNAT) for diagnosis and therapy of inflammatory diseases and sepsis
06/11/2003EP1318405A1 Diagnosis of sepsis determining soluble cytokeratins
06/11/2003EP1318404A1 Diagnosis of sepsis determining CA 19-9
06/11/2003EP1318403A1 Diagnosis of sepsis determining S100B
06/11/2003EP1318402A1 Diagnosis of sepsis determining CA 125
06/11/2003EP1318401A2 Method for the early detection of the seroconversion of an anti hepatitis C virus antibody
06/11/2003EP1318400A1 Method of in vitro diagnostic based on mechanisms of gene regulation and diagnostic reagent therefor
06/11/2003EP1318399A2 Passive sample detection to initiate timing of an assay
06/11/2003EP1318398A1 System and method for health monitoring of aquatic species
06/11/2003EP1318397A1 Test strips having a plurality of reaction zones and methods for using and manufacturing the same
06/11/2003EP1318396A1 Biosensor
06/11/2003EP1318202A1 Method of diagnosing osteoporosis and/or estimating risk of osteoporosis fracture
06/11/2003EP1318195A1 A structure for presenting desired peptide sequences
06/11/2003EP1318194A1 Method of screening hypoglycemic substance by using stat inhibitory factor-1
06/11/2003EP1317927A1 Minor histocompatibility antigen HA-1: target antigen for immunotherapy of tumors
06/11/2003EP1317915A1 Hair nourishments and method of screening the same
06/11/2003EP1317765A2 Automated identification of peptides
06/11/2003EP1317672A2 Method for measuring the activity of the blood clotting factor xiiia
06/11/2003EP1317671A2 Method for measuring antithrombin activity
06/11/2003EP1317670A2 Fluorescence polarization-based homogeneous assay for fumonisin determination in grains